Biotech Series B Investors & VC Firms
900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
BrightEdge
AtlantaSeed–Late Stage
1 person
BSK Investment
SeoulSeed–Late Stage
2 people
Hanne Capital
ShanghaiSeed–Late Stage
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Omron Ventures
KyotoSeed–Growth
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Vesalius Ventures
HoustonSeed–Series B
2 people
Wild Basin Investments
TexasSeed–Growth
2 people
Yonjin Venture LLC
CambridgeSeed–Series B
2 people
Alexandria
PasadenaSeed–Late Stage
1 person
Birk Venture
OsloSeed–Series B
1 person
Ippon
GenevaSeries A–Growth
1 person
Astellas Venture Management
ChicagoSeed–Growth
1 person
Augere Venture
KrakówSeed–Late Stage
1 person
Ilshin Investment Co. Ltd.
SeoulSeed–Late Stage
1 person
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Nan Fung Life Sciences
Hong KongSeed–Growth
1 person
Pittsburgh Life Sciences Greenhouse
PittsburghSeed–Series B
1 person
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
Syngenta Group Ventures
ZurichSeed–Growth
1 person
Brandon Capital Partners
Seed–Growth
E-Crowd
Seed–Growth
JAIC
Palo AltoSeed–Late Stage
Related lists
Series B Investors & VC Firms (4094)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Series B Investors & VC Firms in United States (1625)Biotech Series A Investors & VC Firms (1596)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)Healthtech Series B Investors & VC Firms (1216)Fintech Series B Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.


